glp-1 dementia news Glucose-lowering therapies may reduce risk for dementia, but more research needed GLP-1 receptor agonists show promise

Summary of randomized controlled trials evaluating long-term efficacy and safety of GLP-1 receptor agonists for obesity management

Panton LB et al

Several SGLT-2 inhibitors The possible activity of SGLT2 inhibitors ( n = 9) compared to other hypoglycaemic medications ( n = 7) in patients with T2D and OSA, who initiated CPAP therapy during their administration, was investigated in a recent 3-month study [108]

Common ingredients include: Green tea extract Prebiotics Probiotics Lemon extract Berberine While these ingredients may have some impact on the body, they wouldnt have the same effect as a GLP-1 medication, and definitely shouldnt be used in place of antidiabetics

That means adding more sites, building more partnerships, and making sure each site has the infrastructure and staffing to execute at scale